SG/CALL/EDWARDS LIFESCIENCES/110/0.1/16.01.26

SG/CALL/EDWARDS LIFESCIENCES/110/0.1/16.01.26 Share Price

DE000SW8QPV4

Market Closed - Boerse Frankfurt Warrants 20:44:09 20/05/2024 BST
1.87 ^EUR	+1.63%

Current month	+6.36%
1 month	-6.60%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart SG/CALL/EDWARDS LIFESCIENCES/110/0.1/16.01.26

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences : First Quarter 2024 Fact Sheet	05-15	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	05-13	MT

More news

Quotes 5-day view

Date	Price	Change
20/05/24	1.87	+1.63%
17/05/24	1.84	-4.66%
16/05/24	1.93	+1.58%
15/05/24	1.9	+9.20%
14/05/24	1.74	+6.10%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 08:44 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Société Générale
WKN	SW8QPV
ISIN	DE000SW8QPV4
Date issued	08/04/2024
Strike	110 $
Maturity	16/01/2026 (606 Days)
Parity	10 : 1
Emission price	2.26 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.26 €
Lowest since issue	1.58 €
Spread	0.01 €
Spread %	0.53%

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company